• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy.

作者信息

Wollmann Eva, Lupinek Christian, Kundi Michael, Selb Regina, Niederberger Verena, Valenta Rudolf

机构信息

Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Institute of Environmental Health, Center of Public Health, Medical University of Vienna, Vienna, Austria.

出版信息

J Allergy Clin Immunol. 2015 Sep;136(3):806-809.e7. doi: 10.1016/j.jaci.2015.02.034. Epub 2015 Apr 23.

DOI:10.1016/j.jaci.2015.02.034
PMID:25913196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4559138/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/b4dce9bcd44a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/5110f7b8757e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/24e42a0dfede/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/325802c34c43/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/527e6f324ead/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/91dd270d19d2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/b4dce9bcd44a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/5110f7b8757e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/24e42a0dfede/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/325802c34c43/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/527e6f324ead/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/91dd270d19d2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f324/4559138/b4dce9bcd44a/gr2.jpg

相似文献

1
Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy.通过微阵列测量的变应原特异性IgE结合减少：特异性免疫疗法效果的一种可能替代标志物。
J Allergy Clin Immunol. 2015 Sep;136(3):806-809.e7. doi: 10.1016/j.jaci.2015.02.034. Epub 2015 Apr 23.
2
Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.桦树花粉免疫治疗导致长期丧失 Bet v 1 特异性 TH2 反应、短暂的 TR1 激活和 IgE 阻断抗体的合成。
J Allergy Clin Immunol. 2012 Nov;130(5):1108-1116.e6. doi: 10.1016/j.jaci.2012.07.056. Epub 2012 Sep 27.
3
An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapy.一种可预测白桦树免疫治疗期间 IgG 增强变应原特异性 IgE 结合的发生的检测方法。
Allergy. 2013 Sep;68(9):1199-202. doi: 10.1111/all.12204. Epub 2013 Sep 3.
4
Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses.经鼻应用重组变应原Bet v 1（rBet v 1）或含非IgE反应性T细胞表位的rBet v 1片段，对全身变应原特异性抗体反应有不同影响。
J Allergy Clin Immunol. 2010 Dec;126(6):1312-5.e4. doi: 10.1016/j.jaci.2010.06.008. Epub 2010 Jul 31.
5
Serum immunoglobulin E reactivity to cross-reacting panallergen components in north-eastern Poland patients pollen sensitized.血清免疫球蛋白 E 对波兰东北部花粉致敏患者交叉反应性泛过敏原成分的反应性。
Allergy Asthma Proc. 2020 May 1;41(3):183-191. doi: 10.2500/aap.2020.41.200002.
6
The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy.分子诊断在对草花粉过敏并接受变应原免疫治疗的儿童中的临床意义。
Allergol Immunopathol (Madr). 2019 May-Jun;47(3):309-310. doi: 10.1016/j.aller.2018.12.004. Epub 2019 Feb 6.
7
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.用桦树花粉过敏原Bet v 1的重组低变应原片段对非过敏个体进行疫苗接种：安全性、效果及机制
J Allergy Clin Immunol. 2019 Mar;143(3):1258-1261. doi: 10.1016/j.jaci.2018.11.011. Epub 2018 Nov 22.
8
Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy.过敏原组多肽微阵列可用于过敏原特异性免疫治疗中的表位剖析。
J Allergy Clin Immunol. 2021 Mar;147(3):1077-1086. doi: 10.1016/j.jaci.2020.08.002. Epub 2020 Aug 10.
9
Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.日本雪松花粉舌下免疫疗法对治疗日本雪松和日本扁柏花粉散播期的季节性过敏性鼻炎有效。
Allergol Int. 2022 Jan;71(1):140-143. doi: 10.1016/j.alit.2021.08.012. Epub 2021 Sep 8.
10
Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen.同时对草花粉和橄榄花粉过敏的儿童，免疫治疗方案中分子诊断的分子致敏模式和影响。
Pediatr Allergy Immunol. 2018 Jun;29(4):369-374. doi: 10.1111/pai.12866. Epub 2018 Mar 5.

引用本文的文献

1
Single-Domain Antibodies-Novel Tools to Study and Treat Allergies.单域抗体——研究和治疗过敏的新工具。
Int J Mol Sci. 2024 Jul 11;25(14):7602. doi: 10.3390/ijms25147602.
2
IgE and IgG4 epitopes of the peanut allergens shift following oral immunotherapy.花生过敏原的IgE和IgG4表位在口服免疫治疗后会发生变化。
Front Allergy. 2023 Nov 29;4:1279290. doi: 10.3389/falgy.2023.1279290. eCollection 2023.
3
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation.变应原免疫疗法的机制及临床评估的潜在生物标志物

本文引用的文献

1
Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip.用于过敏诊断和监测的过敏原微阵列技术进展：MeDALL过敏原芯片
Methods. 2014 Mar 1;66(1):106-19. doi: 10.1016/j.ymeth.2013.10.008. Epub 2013 Oct 22.
2
Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients.免疫疗法是针对过敏原的：尘螨和草双重过敏患者中尘螨或 Timothy 提取物的双盲试验。
Int Arch Allergy Immunol. 2012;158(1):63-70. doi: 10.1159/000330649. Epub 2011 Dec 29.
3
Mechanisms of immunotherapy to aeroallergens.
J Pers Med. 2023 May 17;13(5):845. doi: 10.3390/jpm13050845.
4
Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines.携带有完整食物过敏原的马铃薯 Y 病毒重组病毒样颗粒作为免疫治疗疫苗的适用性。
Front Immunol. 2022 Sep 8;13:986823. doi: 10.3389/fimmu.2022.986823. eCollection 2022.
5
Dupilumab modulates specific IgE mite responses at the molecular level in severe T2-high atopic dermatitis: A real-world experience.度普利尤单抗在重度2型高特应性皮炎中在分子水平调节特异性IgE螨反应：一项真实世界经验。
Front Med (Lausanne). 2022 Aug 12;9:939598. doi: 10.3389/fmed.2022.939598. eCollection 2022.
6
The role of allergen-specific IgE, IgG and IgA in allergic disease.过敏原特异性 IgE、IgG 和 IgA 在过敏性疾病中的作用。
Allergy. 2021 Dec;76(12):3627-3641. doi: 10.1111/all.14908. Epub 2021 Jun 8.
7
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy.豚草皮下和舌下免疫治疗后过敏原特异性 IgA 反应的差异诱导。
J Allergy Clin Immunol. 2021 Oct;148(4):1061-1071.e11. doi: 10.1016/j.jaci.2021.03.030. Epub 2021 Apr 2.
8
Microarray-Based Allergy Diagnosis: Quo Vadis?基于微阵列的过敏诊断：何去何从？
Front Immunol. 2021 Feb 12;11:594978. doi: 10.3389/fimmu.2020.594978. eCollection 2020.
9
The use of microarray and other multiplex technologies in the diagnosis of allergy.微阵列和其他多重技术在过敏诊断中的应用。
Ann Allergy Asthma Immunol. 2021 Jul;127(1):10-18. doi: 10.1016/j.anai.2021.01.003. Epub 2021 Jan 12.
10
A WAO - ARIA - GALEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020.WAO - ARIA - GALEN关于基于分子的过敏诊断的共识文件（PAMD@）：2020年更新版
World Allergy Organ J. 2020 Mar 7;13(2):100091. doi: 10.1016/j.waojou.2019.100091. eCollection 2020 Feb.
免疫疗法治疗气传过敏原的机制。
Clin Exp Allergy. 2011 Sep;41(9):1235-46. doi: 10.1111/j.1365-2222.2011.03804.x. Epub 2011 Jul 15.
4
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.重组桦树花粉疫苗治疗桦树过敏性鼻结膜炎的疗效。
J Allergy Clin Immunol. 2008 Nov;122(5):951-60. doi: 10.1016/j.jaci.2008.09.017.
5
The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.IgE 介导的过敏原结合（FAB）检测法：一种基于流式细胞术的新型检测抑制性抗体反应方法的验证
J Immunol Methods. 2006 Dec 20;317(1-2):71-9. doi: 10.1016/j.jim.2006.09.004. Epub 2006 Oct 5.
6
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.每日一次舌下含服草花粉变应原片剂免疫疗法：季节性变应性鼻结膜炎的一项随机对照试验
J Allergy Clin Immunol. 2006 Apr;117(4):802-9. doi: 10.1016/j.jaci.2005.12.1358.
7
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity.用基因改造过敏原进行疫苗接种诱导产生的过敏原特异性鼻内IgG抗体与鼻内过敏原敏感性降低有关。
J Allergy Clin Immunol. 2005 Aug;116(2):347-54. doi: 10.1016/j.jaci.2005.04.003.
8
Vaccination with genetically engineered allergens prevents progression of allergic disease.用基因工程过敏原进行疫苗接种可预防过敏性疾病的进展。
Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14677-82. doi: 10.1073/pnas.0404735101. Epub 2004 Aug 13.
9
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.基于主要桦树花粉过敏原Bet v 1的基因工程低变应原衍生物的桦树花粉过敏疫苗。
Clin Exp Allergy. 2004 Jan;34(1):115-22. doi: 10.1111/j.1365-2222.2004.01857.x.
10
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1.主要桦树花粉过敏原Bet v 1的低变应原性三聚体的基因工程。
FASEB J. 2001 Sep;15(11):2045-7. doi: 10.1096/fj.00-0767fje. Epub 2001 Jul 24.